diclofenac has been researched along with Pancreatic Diseases in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Pancreatic Diseases: Pathological processes of the PANCREAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine whether prophylactic oral diclofenac will reduce the incidence and the severity of ERCP-induced pancreatitis, especially in high-risk patients." | 9.12 | Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. ( Cheon, YK; Cho, KB; Fogel, EL; Lazzell-Pannell, L; Lehman, GA; McHenry, L; Schmidt, S; Sherman, S; Watkins, JL, 2007) |
| "The aim of this study was to determine whether prophylactic oral diclofenac will reduce the incidence and the severity of ERCP-induced pancreatitis, especially in high-risk patients." | 5.12 | Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. ( Cheon, YK; Cho, KB; Fogel, EL; Lazzell-Pannell, L; Lehman, GA; McHenry, L; Schmidt, S; Sherman, S; Watkins, JL, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheon, YK | 1 |
| Cho, KB | 1 |
| Watkins, JL | 1 |
| McHenry, L | 1 |
| Fogel, EL | 1 |
| Sherman, S | 1 |
| Schmidt, S | 1 |
| Lazzell-Pannell, L | 1 |
| Lehman, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of IV Ketorolac to Prevent Post-ERCP Pancreatitis[NCT02465138] | Phase 4 | 0 participants (Actual) | Interventional | 2023-11-30 | Withdrawn (stopped due to Lack of Funding) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for diclofenac and Pancreatic Diseases
| Article | Year |
|---|---|
Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Fema | 2007 |